The Standing Committee on Vaccination recommends the shortening of the interval between the second dose and booster dose of the COVID-19 vaccine to three months and urges all citizens over the age of 18 to receive a booster dose of an mRNA-based vaccine after receiving their first two doses in order to reduce the spread of the SARS-CoV-2 Omicron variant.
The Standing Committee of Vaccination recommends the shortening of interval between the second dose and booster dose of the COVID-19 vaccine to three months and urge its citizens over the age of 18 to receive the booster dose of an mRNA-based vaccines after their completing the first two-dose in order to prevent the spread of the SARS-CoV-2 Omicron variant.
The Standing Committee on Vaccination recommends the shortening of interval between the second dose and booster dose of the COVID-19 vaccine to three months and urge its citizens over the age of 18 to receive the booster dose of an mRNA-based vaccines after their completing the first two-dose in order to prevent the spread of the SARS-CoV-2 Omicron variant.
The Standing Committee on Vaccination recommends the shortening of theinterval between the second dose and booster dose of the COVID-19 vaccine to three months and urges allcitizens over the age of 18 to receive a booster dose of an mRNA-based vaccine after receiving their first twodoses in order to reduce the spread of the SARS-CoV-2 Omicron variant.